» Articles » PMID: 28948469

Dissection of Signaling Events Downstream of the C-Mpl Receptor in Murine Hematopoietic Stem Cells Via Motif-Engineered Chimeric Receptors

Overview
Publisher Springer
Specialty Cell Biology
Date 2017 Sep 27
PMID 28948469
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Hematopoietic stem cells (HSCs) are a valuable resource in transplantation medicine. Cytokines are often used to culture HSCs aiming at better clinical outcomes through enhancement of HSC reconstitution capability. Roles for each signal molecule downstream of receptors in HSCs, however, remain puzzling due to complexity of the cytokine-signaling network. Engineered receptors that are non-responsive to endogenous cytokines represent an attractive tool for dissection of signaling events. We here tested a previously developed chimeric receptor (CR) system in primary murine HSCs, target cells that are indispensable for analysis of stem cell activity. Each CR contains tyrosine motifs that enable selective activation of signal molecules located downstream of the c-Mpl receptor upon stimulation by an artificial ligand. Signaling through a control CR with a wild-type c-Mpl cytoplasmic tail sufficed to enhance HSC proliferation and colony formation in cooperation with stem cell factor (SCF). Among a series of CRs, only one compatible with selective Stat5 activation showed similar positive effects. The HSCs maintained ex vivo in these environments retained long-term reconstitution ability following transplantation. This ability was also demonstrated in secondary recipients, indicating effective transmission of stem cell-supportive signals into HSCs via these artificial CRs during culture. Selective activation of Stat5 through CR ex vivo favored preservation of lymphoid potential in long-term reconstituting HSCs, but not of myeloid potential, exemplifying possible dissection of signals downstream of c-Mpl. These CR systems therefore offer a useful tool to scrutinize complex signaling pathways in HSCs.

Citing Articles

Monoallelic KRAS (G13C) mutation triggers dysregulated expansion in induced pluripotent stem cell-derived hematopoietic progenitor cells.

Lin H, Takagi M, Kubara K, Yamazaki K, Michikawa F, Okumura T Stem Cell Res Ther. 2024; 15(1):106.

PMID: 38627844 PMC: 11021011. DOI: 10.1186/s13287-024-03723-2.


Macrophages Derived From Human Induced Pluripotent Stem Cells: The Diversity of Protocols, Future Prospects, and Outstanding Questions.

Lyadova I, Gerasimova T, Nenasheva T Front Cell Dev Biol. 2021; 9:640703.

PMID: 34150747 PMC: 8207294. DOI: 10.3389/fcell.2021.640703.


TGF-β1 Negatively Regulates the Number and Function of Hematopoietic Stem Cells.

Wang X, Dong F, Zhang S, Yang W, Yu W, Wang Z Stem Cell Reports. 2018; 11(1):274-287.

PMID: 29937145 PMC: 6067088. DOI: 10.1016/j.stemcr.2018.05.017.

References
1.
Touzot F, Hacein-Bey-Abina S, Fischer A, Cavazzana M . Gene therapy for inherited immunodeficiency. Expert Opin Biol Ther. 2014; 14(6):789-98. DOI: 10.1517/14712598.2014.895811. View

2.
Spangrude G, Heimfeld S, Weissman I . Purification and characterization of mouse hematopoietic stem cells. Science. 1988; 241(4861):58-62. DOI: 10.1126/science.2898810. View

3.
Cutler C, Multani P, Robbins D, Kim H, Le T, Hoggatt J . Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation. Blood. 2013; 122(17):3074-81. PMC: 3811179. DOI: 10.1182/blood-2013-05-503177. View

4.
Horwitz M, Chao N, Rizzieri D, Long G, Sullivan K, Gasparetto C . Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment. J Clin Invest. 2014; 124(7):3121-8. PMC: 4071379. DOI: 10.1172/JCI74556. View

5.
Takano H, Ema H, Sudo K, Nakauchi H . Asymmetric division and lineage commitment at the level of hematopoietic stem cells: inference from differentiation in daughter cell and granddaughter cell pairs. J Exp Med. 2004; 199(3):295-302. PMC: 2211802. DOI: 10.1084/jem.20030929. View